Efficacy of PDL laser and topical propranolol in treatment of infantile hemangioma.
Not Applicable
- Conditions
- Infantile Hemangioma.
- Registration Number
- IRCT201110137787N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Inclusion crateria : 1-Hemangioma located in non-sensitive area(include nose-ear-eyelid-lips)
2-Patient compliance with study
3-No previous treatment(with systemic corticosteroids or other drugs) received in the last 3 months.
4-Patients shold not have any systemic involvement(congenital heart disease-renal disease)
5-Hemangioma in the proliferative phase of evolution(age<2 years).
Exclusion crateria:
1-no response after 4 weeks of treatment
2-Allergic reaction to anyone of topical drugs.
3-Side effects of topical propranolol (e.g erythema,pruritus,inflamation......)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of topical propranolol with PDL laser and PDL laser alone in treatment of infantile hemangioma. Timepoint: 0-4-8-12-16 weeks. Method of measurement: Evaluation and comparision of lesion photographs according to VAS(Visual Analogue Scale).
- Secondary Outcome Measures
Name Time Method Improvement of overall health of patient. Timepoint: 4-8-12-16 weeks after initial treatment. Method of measurement: Patients parents.